<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01745666</url>
  </required_header>
  <id_info>
    <org_study_id>RC11_0160</org_study_id>
    <nct_id>NCT01745666</nct_id>
  </id_info>
  <brief_title>Comparison Between Epinephrine and Exercise Test in QT Long Syndrome Patients</brief_title>
  <acronym>QT long</acronym>
  <official_title>Comparison Between Epinephrine and Exercise Test in QT Long Syndrome Patients With KCNQ1 or KCNH2 Mutation Without Long QT Interval in Rest ECG</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Nantes University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Nantes University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the study is to evaluate the best stress exam to unmask long QT in patient with
      KCNQ1 or KCNH2 mutation without long QT interval in rest electrocardiogram.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      65 patients with KCNQ1 or KCNH2 mutation presenting QTc interval &lt;470msec and 65 patients
      without KCNQ1 or KCNH2 mutation presenting QTc interval &lt;470msec will be included.

      All patients will have the 2 tests: exercise test and epinephrine test, in one half day.

      At the end of the inclusions, two experts will examine examens results without knowing in
      which arm (mutated or not) the patient belongs.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>May 2012</start_date>
  <completion_date type="Anticipated">May 2018</completion_date>
  <primary_completion_date type="Anticipated">May 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>to evaluate the best stress exam (exercise test OR epinephrine test)to unmask long QT syndrome.</measure>
    <time_frame>day 1</time_frame>
    <description>Exercise test and epinephrine test will be done at inclusion (day 1). The primary outcome of this study is to evaluate the best stress exam (exercise test versus epinephrine test), defined by a &quot;positive&quot; test to unmask long QT syndrome. Test is positive when QT interval lengthens 30 ms At the end of study inclusions, two reviewers will analyse, independently, electrocardiograms resulting from these tests to determine for each patient if a test was positive and which one. These reviewers will do this job without being informed of the patient status (mutated patient or not mutated patient (control)).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>to evaluate each test characteristics</measure>
    <time_frame>Day 1</time_frame>
    <description>Exercise test and epinephrine test will be done at inclusion (day 1). The secondary outcome is to evaluate each test (exercise test and epinephrine test) characteristics. At the end of study inclusions, two reviewers will independently analyse electrocardiograms resulting from these tests to evaluate their characteristics.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">130</enrollment>
  <condition>Long QT Syndrome Type 1 or 2</condition>
  <arm_group>
    <arm_group_label>patients with KCNQ1 or KCNH2 mutation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>patients WITHOUT KCNQ1 or KCNH2 mutation (control group)</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>exercise test</intervention_name>
    <description>Exercise test : Bruce protocol : exercise during 7 minutes, and rest during 6 minutes with registering of the electrocardiograms.</description>
    <arm_group_label>patients with KCNQ1 or KCNH2 mutation</arm_group_label>
    <arm_group_label>patients WITHOUT KCNQ1 or KCNH2 mutation (control group)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Epinephrine test</intervention_name>
    <description>Epinephrine test : 1 hour after exercise test : epinephrine infusion during 20 minutes, and monitoring during 30 minutes after stop infusion with registering of electrocardiograms.</description>
    <arm_group_label>patients with KCNQ1 or KCNH2 mutation</arm_group_label>
    <arm_group_label>patients WITHOUT KCNQ1 or KCNH2 mutation (control group)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Patients with QTc&lt;470 msec, and with molecular analysis (KCNQ1 or KCNH2 genes) performed in
        order to include 65 patients with KCNQ1 or KCNH2 mutation and 65 patients without KCNQ1 or
        KCNH2 mutation (controls).

        Exclusion Criteria:

          -  QTc interval &gt;470msec

          -  Treatment interfering with cardiac repolarisation

          -  Under 15 years old

          -  Pregnant women

          -  Contraindication to exercise or epinephrine tests

          -  Patients without social coverage
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>15 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Vincent PROBST, PU-PH</last_name>
    <phone>+33 2 40 16 57 00</phone>
    <email>vincent.probst@chu-nantes.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Eric DELANNOY, PH</last_name>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Bordeaux Universitary Hospital</name>
      <address>
        <city>Bordeaux</city>
        <zip>33604</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Frederic SACHER, PH</last_name>
      <phone>+33 5 57 65 64 71</phone>
      <email>frederic.sacher@chu-bordeaux.fr</email>
    </contact>
    <investigator>
      <last_name>Frederic SACHER, PH</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Marseille Universitary Hospital</name>
      <address>
        <city>Marseille</city>
        <zip>13385</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jean-Claude DEHARO, PU-PH</last_name>
      <email>jean-claude.deharo@ap-hm.fr</email>
    </contact>
    <contact_backup>
      <last_name>Eric PEYROUSE, PH</last_name>
      <email>eric.peyrouse@ap-hm.fr</email>
    </contact_backup>
    <investigator>
      <last_name>Jean-Claude DEHARO, PU-PH</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Eric PEYROUSE, PH</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU Montpellier</name>
      <address>
        <city>Montpellier</city>
        <zip>34295</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jean-Luc PASQUIE, PH</last_name>
      <email>jl-pasquie@chu-montpellier.fr</email>
    </contact>
    <investigator>
      <last_name>Jean-Luc PASQUIE, PH</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Nantes Universitary Hospital</name>
      <address>
        <city>Nantes</city>
        <zip>44093</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Vincent PROBST, PU-PH</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Rennes Universitary Hospital</name>
      <address>
        <city>Rennes</city>
        <zip>35033</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Philippe MABO, PU-PH</last_name>
      <email>philippe.mabo@chu-rennes.fr</email>
    </contact>
    <investigator>
      <last_name>Philippe MABO, PU-PH</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU Rouen</name>
      <address>
        <city>Rouen</city>
        <zip>76031</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Frederic ANSELME, PH</last_name>
      <email>frederic.anselme@chu-rouen.fr</email>
    </contact>
    <investigator>
      <last_name>Frederic ANSELME, PH</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU Toulouse</name>
      <address>
        <city>Toulouse</city>
        <zip>31059</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Philippe MAURY, PH</last_name>
      <email>maury.p@chu-toulouse.fr</email>
    </contact>
    <investigator>
      <last_name>Philippe MAURY, PH</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU Tours</name>
      <address>
        <city>Tours</city>
        <zip>37170</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>BABUTY Dominique, PU-PH</last_name>
      <email>d.babuty@chu-tours.fr</email>
    </contact>
    <investigator>
      <last_name>Dominique BABUTY, PU-PH</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>October 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 5, 2012</study_first_submitted>
  <study_first_submitted_qc>December 7, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 10, 2012</study_first_posted>
  <last_update_submitted>October 4, 2016</last_update_submitted>
  <last_update_submitted_qc>October 4, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 5, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Long QT syndrome, stress tests</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Syndrome</mesh_term>
    <mesh_term>Long QT Syndrome</mesh_term>
    <mesh_term>Romano-Ward Syndrome</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Epinephrine</mesh_term>
    <mesh_term>Racepinephrine</mesh_term>
    <mesh_term>Epinephryl borate</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

